These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8660396)

  • 1. Tamoxifen as an antioxidant and cardioprotectant.
    Wiseman H
    Biochem Soc Symp; 1995; 61():209-19. PubMed ID: 8660396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen: new membrane-mediated mechanisms of action and therapeutic advances.
    Wiseman H
    Trends Pharmacol Sci; 1994 Mar; 15(3):83-9. PubMed ID: 8184491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tamoxifen on cardiovascular risk factors in postmenopausal women after 5 years of treatment.
    Love RR; Wiebe DA; Feyzi JM; Newcomb PA; Chappell RJ
    J Natl Cancer Inst; 1994 Oct; 86(20):1534-9. PubMed ID: 7932809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative assessment of lipid effects of endocrine therapy for breast cancer: implications for cardiovascular disease prevention in postmenopausal women.
    Esteva FJ; Hortobagyi GN
    Breast; 2006 Jun; 15(3):301-12. PubMed ID: 16230014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of tamoxifen and estrogen replacement therapy on lipid metabolism and some other cardiovascular risk factors. A prospective study in hysterectomised women].
    Imperato F; Marziani R; Perniola G; Ebano V; Fruscella M; Mossa B
    Minerva Ginecol; 2003 Feb; 55(1):87-93. PubMed ID: 12598849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of tamoxifen on cardiovascular risk factors in postmenopausal women.
    Love RR; Wiebe DA; Newcomb PA; Cameron L; Leventhal H; Jordan VC; Feyzi J; DeMets DL
    Ann Intern Med; 1991 Dec; 115(11):860-4. PubMed ID: 1952472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective actions of tamoxifen and 4-hydroxytamoxifen against oxidative damage to human low-density lipoproteins: a mechanism accounting for the cardioprotective action of tamoxifen?
    Wiseman H; Paganga G; Rice-Evans C; Halliwell B
    Biochem J; 1993 Jun; 292 ( Pt 3)(Pt 3):635-8. PubMed ID: 8317992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antioxidant action of synthetic oestrogens involves decreased membrane fluidity: relevance to their potential use as anticancer and cardioprotective agents compared to tamoxifen?
    Wiseman H; Quinn P
    Free Radic Res; 1994 Sep; 21(3):187-94. PubMed ID: 7981789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen and related compounds decrease membrane fluidity in liposomes. Mechanism for the antioxidant action of tamoxifen and relevance to its anticancer and cardioprotective actions?
    Wiseman H; Quinn P; Halliwell B
    FEBS Lett; 1993 Sep; 330(1):53-6. PubMed ID: 8370459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma lipids and lipoprotein alterations in tamoxifen-treated breast cancer women in relation to the menopausal status.
    Ilanchezhian S; Thangaraju M; Sachdanandam P
    Cancer Biochem Biophys; 1995 Nov; 15(2):83-90. PubMed ID: 8590439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of tamoxifen on serum cholesterol and lipoproteins during chemohormonal therapy.
    Dnistrian AM; Schwartz MK; Greenberg EJ; Smith CA; Schwartz DC
    Clin Chim Acta; 1993 Dec; 223(1-2):43-52. PubMed ID: 8143369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmented antioxidant status in Tamoxifen treated postmenopausal women with breast cancer on co-administration with Coenzyme Q10, Niacin and Riboflavin.
    Yuvaraj S; Premkumar VG; Vijayasarathy K; Gangadaran SG; Sachdanandam P
    Cancer Chemother Pharmacol; 2008 May; 61(6):933-41. PubMed ID: 17668211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of exemestane on the lipidemic profile of postmenopausal early breast cancer patients: preliminary results of the TEAM Greek sub-study.
    Markopoulos C; Polychronis A; Zobolas V; Xepapadakis G; Papadiamantis J; Koukouras D; Lappas H; Gogas H
    Breast Cancer Res Treat; 2005 Sep; 93(1):61-6. PubMed ID: 16184460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ameliorating effect of coenzyme Q10, riboflavin and niacin in tamoxifen-treated postmenopausal breast cancer patients with special reference to lipids and lipoproteins.
    Yuvaraj S; Premkumar VG; Vijayasarathy K; Gangadaran SG; Sachdanandam P
    Clin Biochem; 2007 Jun; 40(9-10):623-8. PubMed ID: 17425952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen use, oestrogen binding and serum lipids in postmenopausal women with breast cancer.
    Ingram D
    Aust N Z J Surg; 1990 Sep; 60(9):673-5. PubMed ID: 2396945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are the effects of tamoxifen on the serum lipid profile modified by apolipoprotein E phenotypes?
    Liberopoulos E; Karabina SA; Tselepis A; Bairaktari E; Nicolaides C; Pavlidis N; Elisaf M
    Oncology; 2002; 62(2):115-20. PubMed ID: 11914596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of long-term tamoxifen therapy modifies the plasma lipoprotein-lipid concentration and lipid transfer protein I activity in postmenopausal women with breast cancer.
    Wasan KM; Ramaswamy M; Haley J; Dunn BP
    J Pharm Sci; 1997 Jul; 86(7):876-9. PubMed ID: 9232532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tamoxifen on lipids and lipid metabolising marker enzymes in experimental atherosclerosis in Wistar rats.
    Vinitha R; Thangaraju M; Sachdanandam P
    Mol Cell Biochem; 1997 Mar; 168(1-2):13-9. PubMed ID: 9062889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant tamoxifen in primary breast cancer: influence on plasma lipids and antithrombin III levels.
    Bertelli G; Pronzato P; Amoroso D; Cusimano MP; Conte PF; Montagna G; Bertolini S; Rosso R
    Breast Cancer Res Treat; 1988 Dec; 12(3):307-10. PubMed ID: 3228593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer.
    Love RR; Newcomb PA; Wiebe DA; Surawicz TS; Jordan VC; Carbone PP; DeMets DL
    J Natl Cancer Inst; 1990 Aug; 82(16):1327-32. PubMed ID: 2199681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.